Robin Kramer
Sr VP, ChiefAccountingOfficer, Herc Holdings Inc.
Companies
- BiogenChief financial officer Feb 10, 2026 to now1
- Armata Pharmaceuticals, Inc.Board member Dec 9, 2020 to now2
- BiogenVP, Chief Accounting Officer Nov 19, 2018 to Feb 12, 20253
- Hertz Car SalesSr VP, ChiefAccountingOfficer Jun 8, 2016 to May 1, 20184
- Herc Holdings Inc.Sr VP, ChiefAccountingOfficer May 27, 2014 to May 18, 20165
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
As of each latest filing. The line shows shares held over time.
Recent filings
- Feb 6, 2026Shares withheld for tax 1,063 shares at $201.18 of Biogen6
- Feb 6, 2026Exercised options 3,511 shares of Biogen6
- Feb 6, 2026Shares withheld for tax 207 shares at $201.18 of Biogen6
- Feb 6, 2026Exercised options 703 shares of Biogen6
- Feb 6, 2026Shares withheld for tax 273 shares at $201.18 of Biogen6
- Feb 6, 2026Exercised options 789 shares of Biogen6
- Feb 10, 2025Shares withheld for tax 245 shares at $142.54 of Biogen7
- Feb 10, 2025Exercised options 834 shares of Biogen7
- Feb 7, 2025Shares withheld for tax 244 shares at $141.35 of Biogen8
- Feb 7, 2025Exercised options 703 shares of Biogen8
- Feb 7, 2025Shares withheld for tax 232 shares at $141.35 of Biogen8
- Feb 7, 2025Exercised options 788 shares of Biogen8
- Dec 6, 2024Shares withheld for tax 170 shares at $157.78 of Biogen9
- Dec 6, 2024Exercised options 351 shares of Biogen9
- Feb 16, 2024Shares withheld for tax 127 shares at $219.08 of Biogen10
- Feb 16, 2024Exercised options 431 shares of Biogen10
- Feb 16, 2024Shares withheld for tax 269 shares at $219.08 of Biogen10
- Feb 16, 2024Exercised options 914 shares of Biogen10
- Feb 9, 2024Shares withheld for tax 245 shares at $240.98 of Biogen11
- Feb 9, 2024Exercised options 833 shares of Biogen11
- Feb 8, 2024Shares withheld for tax 253 shares at $240.30 of Biogen12
- Feb 8, 2024Exercised options 788 shares of Biogen12
- Dec 8, 2023Shares withheld for tax 170 shares at $239.29 of Biogen13
- Dec 8, 2023Exercised options 351 shares of Biogen13
- Jun 30, 2023Shares withheld for tax 122 shares at $284.85 of Biogen14
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARBiogen, Chief financial officer
- 2
- 3SEC EDGARBiogen, VP, Chief Accounting Officer
- 4
- 5
- 6
- 7SEC EDGARForm 4 filed Feb 12, 2025
- 8SEC EDGARForm 4 filed Feb 10, 2025
- 9SEC EDGARForm 4 filed Dec 9, 2024
- 10SEC EDGARForm 4 filed Feb 21, 2024
- 11SEC EDGARForm 4 filed Feb 13, 2024
- 12SEC EDGARForm 4 filed Feb 9, 2024
- 13SEC EDGARForm 4 filed Dec 12, 2023
- 14SEC EDGARForm 4 filed Jul 5, 2023